JP2012529423A5 - - Google Patents

Download PDF

Info

Publication number
JP2012529423A5
JP2012529423A5 JP2011552249A JP2011552249A JP2012529423A5 JP 2012529423 A5 JP2012529423 A5 JP 2012529423A5 JP 2011552249 A JP2011552249 A JP 2011552249A JP 2011552249 A JP2011552249 A JP 2011552249A JP 2012529423 A5 JP2012529423 A5 JP 2012529423A5
Authority
JP
Japan
Prior art keywords
amino acid
seq
peptide
modified
leucine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011552249A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012529423A (ja
JP5688587B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2011552249A priority Critical patent/JP5688587B2/ja
Priority claimed from PCT/JP2010/003871 external-priority patent/WO2010143435A1/en
Publication of JP2012529423A publication Critical patent/JP2012529423A/ja
Publication of JP2012529423A5 publication Critical patent/JP2012529423A5/ja
Application granted granted Critical
Publication of JP5688587B2 publication Critical patent/JP5688587B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011552249A 2009-06-11 2010-06-10 脈絡膜新血管新生に対するワクチン療法 Expired - Fee Related JP5688587B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2011552249A JP5688587B2 (ja) 2009-06-11 2010-06-10 脈絡膜新血管新生に対するワクチン療法

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2009140363 2009-06-11
JP2009140363 2009-06-11
PCT/JP2010/003871 WO2010143435A1 (en) 2009-06-11 2010-06-10 Vaccine therapy for choroidal neovascularization
JP2011552249A JP5688587B2 (ja) 2009-06-11 2010-06-10 脈絡膜新血管新生に対するワクチン療法

Publications (3)

Publication Number Publication Date
JP2012529423A JP2012529423A (ja) 2012-11-22
JP2012529423A5 true JP2012529423A5 (https=) 2013-07-25
JP5688587B2 JP5688587B2 (ja) 2015-03-25

Family

ID=43308696

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011552249A Expired - Fee Related JP5688587B2 (ja) 2009-06-11 2010-06-10 脈絡膜新血管新生に対するワクチン療法

Country Status (14)

Country Link
US (1) US8975229B2 (https=)
EP (1) EP2440226A4 (https=)
JP (1) JP5688587B2 (https=)
KR (1) KR20120038419A (https=)
CN (1) CN102802654A (https=)
AU (1) AU2010259797B2 (https=)
BR (1) BRPI1013025A2 (https=)
CA (1) CA2764562A1 (https=)
IL (1) IL216402A0 (https=)
MX (1) MX2011012659A (https=)
RU (1) RU2555345C2 (https=)
SG (2) SG10201403109VA (https=)
TW (1) TW201109029A (https=)
WO (1) WO2010143435A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2095822T3 (da) 2005-02-28 2014-01-13 Oncotherapy Science Inc Epitoppeptider afledt af karendothelvækstfaktorreceptor-1 samt vacciner indeholdende disse peptider
AU2008215432B2 (en) * 2007-02-16 2013-03-21 Oncotherapy Science, Inc. Vaccine therapy for choroidal neovascularization
FR2990352A1 (fr) 2012-05-10 2013-11-15 Univ Paris 13 Composition immunogene comprenant un peptide derive du vegf et ses utilisations
WO2018212358A1 (ja) * 2017-05-19 2018-11-22 学校法人慶應義塾 脳神経疾患に対するペプチドワクチン及びペプチドワクチン組成物

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5861301A (en) 1992-02-20 1999-01-19 American Cayanamid Company Recombinant kinase insert domain containing receptor and gene encoding same
CN1701814A (zh) 1992-11-13 2005-11-30 马克斯普朗克科学促进协会 作为血管内皮生长因子受体的f1k-1
CA2158745C (en) 1993-03-25 2007-06-19 Richard L. Kendall Inhibitor of vascular endothelial cell growth factor
US6100071A (en) 1996-05-07 2000-08-08 Genentech, Inc. Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production
US6080728A (en) 1996-07-16 2000-06-27 Mixson; A. James Carrier: DNA complexes containing DNA encoding anti-angiogenic peptides and their use in gene therapy
DE19638745C2 (de) 1996-09-11 2001-05-10 Schering Ag Monoklonale Antikörper gegen die extrazelluläre Domäne des menschlichen VEGF - Rezeptorproteins (KDR)
WO1998031794A1 (fr) 1997-01-17 1998-07-23 Toa Gosei Co., Ltd. Polypeptide liant le facteur vegf
WO1998058053A1 (en) 1997-06-18 1998-12-23 Merck & Co., Inc. Human receptor tyrosine kinase, kdr
WO1999040118A1 (en) 1998-02-04 1999-08-12 Kyowa Hakko Kogyo Co., Ltd. Antibodies against human vegf receptor kdr
GB9804121D0 (en) 1998-02-26 1998-04-22 Cancer Res Campaign Tech Anti-angiogenic vaccines: materials and methods relating thereto
CA2328893A1 (en) 1998-05-20 1999-11-25 Kyowa Hakko Kogyo Co., Ltd. Vegf activity inhibitors
WO2001012809A2 (en) 1999-08-13 2001-02-22 Crucell Holland B.V. Heterodimeric vegf variants used for inhibiting angiogenesis
US7264810B2 (en) 2001-01-19 2007-09-04 Cytos Biotechnology Ag Molecular antigen array
AU2002362461A1 (en) 2001-10-01 2003-04-14 Targesome, Inc. Targeted therapeutic lipid constructs having cell surface targets
CU23178A1 (es) 2002-04-15 2006-09-22 Ct Ingenieria Genetica Biotech INMUNOTERAPIA ACTIVA ANTIANGIOGéNICA
DE60327786D1 (de) 2002-09-12 2009-07-09 Oncotherapy Science Inc Kdr-peptide und diese enthaltende impfstoffe
DK1539157T3 (da) 2002-09-18 2013-10-07 Univ Pennsylvania Fremgangsmåde til hæmning af choroidal neovaskularisering
CN1926551B (zh) 2003-10-27 2010-06-16 罗斯塔生化科技有限责任公司 用于基因沉默的siRNA的设计方法
JP2006215988A (ja) * 2005-02-07 2006-08-17 Ntt Docomo Kansai Inc 認証システム、携帯端末装置及び認証方法
DK2095822T3 (da) * 2005-02-28 2014-01-13 Oncotherapy Science Inc Epitoppeptider afledt af karendothelvækstfaktorreceptor-1 samt vacciner indeholdende disse peptider
US20060234941A1 (en) * 2005-04-15 2006-10-19 The Gov. Of The Usa As Represented By The Secretary Of The Dept. Of Health & Human Services Peptide epitopes of VEGFR-2/KDR that inhibit angiogenesis
JP2006315988A (ja) 2005-05-11 2006-11-24 Mototake Shimizu ケモカイン産生誘導効果を有する血管新生阻害物質
AU2008215432B2 (en) 2007-02-16 2013-03-21 Oncotherapy Science, Inc. Vaccine therapy for choroidal neovascularization
EP2171082B1 (en) 2007-06-14 2012-11-28 Oncotherapy Science, Inc. Methods of identifying agents that modulate methylation of vegfr1 by smyd3
TWI436775B (zh) 2007-08-24 2014-05-11 Oncotherapy Science Inc 以抗原胜肽合併化療藥劑治療胰臟癌

Similar Documents

Publication Publication Date Title
JP2012500001A5 (https=)
TWI482626B (zh) 胃腸道病症的治療
JP6585720B2 (ja) 眼疾患治療のペプチド及びこれを含む眼疾患治療用組成物
JP2022513223A5 (https=)
CN105939723B (zh) 前列腺癌治疗用组合物
JP2014521684A5 (https=)
JP7672122B2 (ja) 生物活性複合体の調製
CN104619727A (zh) 靶向治疗
CN106232616A (zh) 两亲性合成抗菌肽、其药物组合物及其用途
RS61230B1 (sr) Lečenje neuroloških bolesti
JP2012517799A5 (https=)
JP2014506450A5 (https=)
JP2016510728A5 (https=)
JP2015504052A5 (https=)
JP2019535651A5 (https=)
JP2006506942A5 (https=)
JP2016536369A5 (https=)
CN110945010A (zh) 肽组合物和相关方法
JP2012529423A5 (https=)
HRP20140886T1 (hr) MUTANTI CyaA POLIPEPTIDI I POLIPEPTIDNI DERIVATI PRIKLADNI ZA DOPREMANJE IMUNOGENIÄŚNIH MOLEKULA U STANICU
CN120981479A (zh) Gip/glp1/gcg三受体激动剂及其用途
RU2012100241A (ru) Лечение хориоидальной неоваскуляризации с помощью вакцин
JP2018533912A5 (https=)
US12552848B2 (en) Hydrochloride salts of C5a receptor agonist peptides
RU2013103487A (ru) Вакцинотерапия неоваскуляризации сосудистой оболочки глаза